Daniel B Carr insider trades: Javelin Pharmaceuticals (JAV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 3, 2010 | JAV | ↓ Sell | 18,450 | $2.18 | $40K | Direct | May 5, 2010 (2d) |
| Mar 26, 2010 | JAV | ↓ Sell | 5,400 | $1.35 | $7K | Direct | Mar 29, 2010 (3d) |
| May 13, 2008 | AMEX:JAV | ↑ Buy | 20,746 | $2.41 | $50K | Direct | May 15, 2008 (2d) |
| Nov 22, 2006 | AMEX:JAV | ↑ Buy | 4,000 | $3.45 | $14K | Direct | Nov 27, 2006 (5d) |
| Dec 1, 2005 | JVPH:OB | ↑ Buy | 2,000 | $3.15 | $6K | Direct | Dec 5, 2005 (4d) |
| Nov 22, 2005 | JVPH.OB | ↑ Buy | 2,000 | $3.10 | $6K | Direct | Nov 23, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel B Carr's insider trades
Daniel B Carr is President and CMO at Javelin Pharmaceuticals (JAV). Since Nov 22, 2005, Daniel has reported 4 open-market purchases worth $76K and 2 sales worth $48K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JAV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.